Μετάβαση στο περιεχόμενο
Global sound
The Readout Loud

The Readout Loud

391: Breaching the IBD efficacy ceiling, and sham surgeries

· 30 λεπ.

Σημειώσεις επεισοδίου

Will drugmakers finally be able to breach the efficacy ceiling in inflammatory bowel disease? And is the Food and Drug Administration being flexible enough with rare disease treatments?

Spyre Therapeutics CEO Cameron Turtle joins the podcast to discuss his company's experimental IBD medications, and whether the drug industry is scraping the barrel in the search for better treatments. We also discuss the latest news in the life sciences, including the ongoing debate between the FDA and UniQure over its Huntington's disease therapy, as well as Moderna's mammoth patent settlement.

Ζωντανά, τελευταία ώρα: 8.248 τραγούδια σε 3.070 σταθμούς σε 122 χώρες

Ανακαλύψτε τον κόσμο μέσα από το ραδιόφωνο

Περισσότεροι τρόποι ανακάλυψης (7)

Ακούσατε κάτι ωραίο; Αποθηκεύστε το ή ανοίξτε το απευθείας στο Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
NDR 1 Niedersachsen (OL)Συνέχεια ακρόασης